Medifocus Inc
Medifocus Inc's email is jmon@medifocusinc.com
and
Medifocus Inc's phone number is 14102907255
.
Medifocus, Inc. (TSXV-MFS, OTC-MDFZF) develops and commercializes minimally invasive treatment systems used in treatment of cancerous and benign tumors, and enlarged prostate, medically known as Benign Prostatic Hyperplasia (“BPH”). The Company owns two technology platforms with approximately 100 issued and pending US and international patents: Based on these proprietary technology platforms, the Company has developed two advanced therapeutic products: the Adaptive Phased Array (APA)-1000 system for treatment of breast cancer and the Prolieve® system for the treatment...
read more
Medifocus, Inc. (TSXV-MFS, OTC-MDFZF) develops and commercializes minimally invasive treatment systems used in treatment of cancerous and benign tumors, and enlarged prostate, medically known as Benign Prostatic Hyperplasia (“BPH”). The Company owns two technology platforms with approximately 100 issued and pending US and international patents: Based on these proprietary technology platforms, the Company has developed two advanced therapeutic products: the Adaptive Phased Array (APA)-1000 system for treatment of breast cancer and the Prolieve® system for the treatment of BPH. The APA-1000 uses precisely focused and controlled microwave energy to shrink breast cancer tumors without side-effects on the surrounding tissues to produce better treatment outcomes. The Company has received regulatory approvals to complete the APA 1000’s pivotal Phase-III clinical trials, the final step before marketing approval. The U.S. FDA-approved Prolieve® System is a medical device based on endo-thermotherapy that both heats the prostate and dilates the prostatic urethra. The Prolieve® System is a minimally invasive in-office treatment option for the symptoms of enlarged prostate in men. The Prolieve® System is a revenue generating product catering to the multi billion dollar BPH market. The Company is currently focusing on marketing Prolieve® for the treatment of BPH and accelerating the APA 1000 breast cancer system’s Phase III study.
show less
Website | medifocusinc.com | |
Industry | Biotechnology | |
Location | United States | |
Employees | 3 |
HQ | 10240 Old Columbia Rd. Suite G | |
Phone | 1410-290-7255 | |
jmon@medifocusinc.com | ||
Funding | 5,500,000 USD | |
Competitors | Roche, Agilent Technologies, Amgen, Genentech, Eurofins, Gilead Sciences, |
Website | medifocusinc.com | |
Industry | Biotechnology | |
Location | United States | |
Employees | 3 | |
linkedin.com/company/medifocus-inc | ||
HQ | 10240 Old Columbia Rd. Suite G | |
Phone | 1410-290-7255 | |
jmon@medifocusinc.com | ||
Funding | 5,500,000 USD |
Email Patterns for Medifocus Inc
Top Competitors for Medifocus Inc
Medifocus Inc Questions
Where are Medifocus Inc's headquarters?
Medifocus Inc's headquarters are in 10240 Old Columbia Rd. Suite G
What is Medifocus Inc's phone number?
Medifocus Inc's phone number is 14102907255
What is Medifocus Inc's official website?
Medifocus Inc's website is medifocusinc.com
How many employees are working in Medifocus Inc right now?
Medifocus Inc has
3 employees.
View the Email and Phone Numbers for all 3 working at Medifocus Inc.
What is Medifocus Inc's industry?
Medifocus Inc's industry is
Biotechnology
Who are Medifocus Inc's top competitors?
Medifocus Inc's top competitors are
Roche
,
Agilent Technologies
,
Amgen
,
Genentech
,
Eurofins
,
Gilead Sciences
What is Medifocus Inc's email address?
Medifocus Inc's email address is jmon@medifocusinc.com
What are Medifocus Inc's categories?
Medifocus Inc's categories are Biotechnology, Commercial, Medical
What is Medifocus Inc's location?
Medifocus Inc's location is
United States
What is Medifocus Inc's funding?
Medifocus Inc's funding is 5,500,000 USD
What is Medifocus Inc's current status?
Medifocus Inc's current status is ipo
Top Medifocus Inc Employees
Managing Director
gytis.bendorius@tamro.lt
+3706-988-8300
Senior Vice President
az@medifocus.com
+1301-649-9300
General Manager And Regulatory Affairs
jmon@medifocususa.com
+1301-649-9300
Medical Doctor
Managing Director
gytis.bendorius@tamro.lt
+3706-988-8300
Senior Vice President
az@medifocus.com
+1301-649-9300
General Manager And Regulatory Affairs
jmon@medifocususa.com
+1301-649-9300